Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
The role of MRI in the evaluation of secondary progressive multiple sclerosis.
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
Early recognition and diagnosis of multiple sclerosis.
Robot Training of Upper Limb in Multiple Sclerosis: Comparing Protocols With or WithoutManipulative Task Components.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Iron in multiple sclerosis: roles in neurodegeneration and repair.
Detecting clinically-relevant changes in progressive multiple sclerosis.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Cystoid macular oedema after fingolimod treatment in multiple sclerosis.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Pulmonary Hypertension and Multiple Sclerosis - Coincidence or Association?
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Application of the fuzzy logic concept in the multiple sclerosis functional composite for scoring the progress of multiple sclerosis.
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.
[Association between depression and cognitive decline in sclerosis multiplex patients].
Pages
« first
‹ previous
…
253
254
255
256
257
258
259
260
261
…
next ›
last »